REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
14/07/2025
Voltar para busca
Dado oficial do USPTO
BLACKTHORN THERAPEUTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
62
Atualização mais recente
15/07/2025
Tipo de marca
Mista
Classes Nice
35, 42
Data de depósito
06/05/2016
Data de registro
14/07/2020
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
14/07/2020
Última transação
15/07/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
01/01/2017
Primeiro uso no comércio
01/01/2017
Código do desenho
3
Tipo de titular
03
Localização do titular
BRISBANE, CA
Examinador
CRENNAN, KEVIN
Unidade examinadora
M40
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of a schematic depiction of a human brain in which individual brain regions are conceptually illustrated through the use of shaded circles interconnected by lines and are connected to other brain regions which, together, comprise brain or neural circuits that is located to the left of the company name "BLACKTHORN THERAPEUTICS".
Titulares e representantes
Titulares
NEUMORA THERAPEUTICS, INC.
BlackThorn Therapeutics, Inc.
BlackThorn Therapeutics, Inc.
BlackThorn Therapeutics, Inc.
Representantes
Lisa Greenwald-Swire Fish & Richardson P.C.
Classificação técnica
Classes Nice
Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Marketing of pharmaceutical preparations for the treatment of brain disorders
Classe 42
Development of pharmaceutical preparations for the treatment of brain disorders
Publicações
Histórico de despachos e eventos da marca no USPTO.
62 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/06/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/06/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/06/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/06/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/06/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
10/05/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/04/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/04/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/04/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/04/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/04/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
14/05/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
14/05/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14/05/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14/05/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
14/05/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
14/07/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
15/06/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
15/06/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
15/06/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/06/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/06/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/06/2020
IUAF
USE AMENDMENT FILED
08/06/2020
EISU
TEAS STATEMENT OF USE RECEIVED
08/06/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
26/11/2019
EX5G
SOU EXTENSION 5 GRANTED
25/11/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
25/11/2019
EXT5
SOU EXTENSION 5 FILED
21/11/2019
EEXT
SOU TEAS EXTENSION RECEIVED
21/11/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
30/05/2019
EX4G
SOU EXTENSION 4 GRANTED
28/05/2019
EXT4
SOU EXTENSION 4 FILED
28/05/2019
EEXT
SOU TEAS EXTENSION RECEIVED
28/05/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
13/12/2018
EX3G
SOU EXTENSION 3 GRANTED
11/12/2018
EXT3
SOU EXTENSION 3 FILED
11/12/2018
EEXT
SOU TEAS EXTENSION RECEIVED
11/12/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
14/06/2018
EX2G
SOU EXTENSION 2 GRANTED
12/06/2018
EXT2
SOU EXTENSION 2 FILED
12/06/2018
EEXT
SOU TEAS EXTENSION RECEIVED
12/06/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
15/12/2017
EX1G
SOU EXTENSION 1 GRANTED
13/12/2017
EXT1
SOU EXTENSION 1 FILED
13/12/2017
EEXT
SOU TEAS EXTENSION RECEIVED
13/12/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
20/06/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
25/04/2017
PUBO
PUBLISHED FOR OPPOSITION
25/04/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/04/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/03/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/02/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/02/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/02/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
29/08/2016
GNRT
NON-FINAL ACTION E-MAILED
29/08/2016
CNRT
NON-FINAL ACTION WRITTEN
29/08/2016
DOCK
ASSIGNED TO EXAMINER
22/08/2016
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
12/05/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/05/2016
NWAP
NEW APPLICATION ENTERED
10/05/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BLACKTHORN THERAPEUTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.